Overpromotion of drugs in international product package inserts.
D004348:Drug Labeling; D009549:Nigeria; D011224:Prazosin / Q000009:adverse effects*; D011799:Quinazolines / Q000009:adverse effects*; D014481:United States
D011799:Quinazolines; D011224:Prazosin